Groopman JE - Search Results

1

Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine.

Allan JD, Connolly KJ, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE. Allan JD, et al. Among authors: groopman je. Clin Infect Dis. 1993 Feb;16 Suppl 1:S46-51. doi: 10.1093/clinids/16.supplement_1.s46. Clin Infect Dis. 1993. PMID: 8425019 Clinical Trial.

2

Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.

Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE. Connolly KJ, et al. Among authors: groopman je. Am J Med. 1991 Nov;91(5):471-8. doi: 10.1016/0002-9343(91)90182-w. Am J Med. 1991. PMID: 1659189 Clinical Trial.

3

Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.

Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE. Levine JD, et al. Among authors: groopman je. Blood. 1991 Dec 15;78(12):3148-54. Blood. 1991. PMID: 1742482 Free article. Clinical Trial.

4

Zidovudine intolerance.

Groopman JE. Groopman JE. Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S500-6. doi: 10.1093/clinids/12.supplement_5.s500. Rev Infect Dis. 1990. PMID: 2201071 Review.

5

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al. Kahn JO, et al. Among authors: groopman je. Ann Intern Med. 1990 Feb 15;112(4):254-61. doi: 10.7326/0003-4819-112-4-. Ann Intern Med. 1990. PMID: 2297204

6

Management of the hematologic complications of human immunodeficiency virus infection.

Groopman JE. Groopman JE. Rev Infect Dis. 1990 Sep-Oct;12(5):931-7. doi: 10.1093/clinids/12.5.931. Rev Infect Dis. 1990. PMID: 2237134 Review.

7

Human T-lymphotropic virus type III infection in previously immunocompromised hosts.

Groopman JE, Hammer SM, Sallan SE, Allan JD. Groopman JE, et al. J Clin Oncol. 1986 Apr;4(4):540-3. doi: 10.1200/JCO.1986.4.4.540. J Clin Oncol. 1986. PMID: 3007685

8

Characterization of serum neutralization response to the human immunodeficiency virus (HIV).

Groopman JE, Benz PM, Ferriani R, Mayer K, Allan JD, Weymouth LA. Groopman JE, et al. AIDS Res Hum Retroviruses. 1987 Spring;3(1):71-85. doi: 10.1089/aid.1987.3.71. AIDS Res Hum Retroviruses. 1987. PMID: 2441727

9

Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.

Scadden DT, Bering HA, Levine JD, Bresnahan J, Evans L, Epstein C, Groopman JE. Scadden DT, et al. Among authors: groopman je. J Clin Oncol. 1991 May;9(5):802-8. doi: 10.1200/JCO.1991.9.5.802. J Clin Oncol. 1991. PMID: 2016623 Clinical Trial.

10

Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction.

Scadden DT, Wang Z, Groopman JE. Scadden DT, et al. Among authors: groopman je. J Infect Dis. 1992 Jun;165(6):1119-23. doi: 10.1093/infdis/165.6.1119. J Infect Dis. 1992. PMID: 1583331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters